Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)

Frontiers in immunology

Raju Sunagar, Sai D Prasad, Raches Ella, …, Sai D Prasad, Raches Ella, Krishna Mohan Vadrevu

• DOI: 10.3389/fimmu.2022.1063679
• PMID: 36569867
• PMCID: PMC9773076